Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
08/29/1996 | WO1996018735A3 Tgf-beta superfamily type ii receptor having binding affinity for bone morphogenic protein (bmp) |
08/29/1996 | WO1996017960A3 Methods for inhibiting the transcription-enhancing activity of the x protein of hepatitis b virus |
08/29/1996 | WO1996017937A3 Pesticidal composition comprising cryif chimeric and cryia(c) chimeric bacillus thuringiensis delta-endotoxin |
08/29/1996 | WO1996017927A3 Reporter cell line |
08/29/1996 | WO1996017869A3 Interleukin-6 (il-6) antagonists |
08/29/1996 | WO1996017068A3 Pathogen-resistant plants and method for producing them |
08/29/1996 | WO1996017059A3 Receptor for cell-binding domain of thrombospondins |
08/29/1996 | WO1996016172A3 Modulators of anchoring protein function |
08/29/1996 | WO1996014412A3 cDNA ENCODING A BMP TYPE II RECEPTOR |
08/29/1996 | WO1996009391A3 Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19 |
08/29/1996 | DE19539130A1 Mittel zur Therapie von Tumoren und anderen Hyperplasien Means for the therapy of tumors and other hyperplasias |
08/29/1996 | DE19506669A1 Lipoxygenase inhibitor for treating asthma, tumours, shock etc. |
08/29/1996 | DE19506633A1 Verfahren zur Herstellung von Faktor IX aus biologischen Quellen A process for the preparation of factor IX from biological sources |
08/29/1996 | DE19506362A1 Prodn. of cytokine mixt. for use in cancer therapy |
08/29/1996 | CA2566828A1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) |
08/29/1996 | CA2213610A1 Ingap protein involved in pancreatic islet neogenesis |
08/29/1996 | CA2213561A1 Novel bacteriocin piscicolin 126 |
08/29/1996 | CA2213484A1 Modulators of regulatory proteins |
08/29/1996 | CA2213469A1 Novel osteoclastogenesis inhibitory factor and methods for producing same |
08/29/1996 | CA2213451A1 Generation of human cytotoxic t-cells specific for carcinoma self-associated antigens and uses thereof |
08/29/1996 | CA2213417A1 Novel cationic lipids and the use thereof |
08/29/1996 | CA2213410A1 Expression of gene products from genetically manipulated strains of bordetella |
08/29/1996 | CA2213337A1 Isolated nonapeptides presented by hla molecules, and uses thereof |
08/29/1996 | CA2212870A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
08/29/1996 | CA2212846A1 Prostate-specific membrane antigen and uses thereof |
08/29/1996 | CA2211995A1 Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation |
08/29/1996 | CA2211630A1 Peptides for tissue and cell culture media |
08/29/1996 | CA2197675A1 Transgenically produced antithrombin iii |
08/28/1996 | EP0728842A2 Live recombinant avian vaccine based on an avianherpes virus, against Gumboro disease |
08/28/1996 | EP0728764A1 Peptide capable of inducing immune response against hiv and aids preventive or remedy containing the peptide |
08/28/1996 | EP0728482A2 Use of hcp specific compounds to enhance erythropoiesis |
08/28/1996 | EP0728217A1 Nucleic acid mutation detection by analysis of sputum |
08/28/1996 | EP0728215A1 METHOD OF BINDING MATERIAL TO THE $g(b)-AMYLOID PEPTIDE |
08/28/1996 | EP0728214A1 Stable cell lines capable of expressing the adeno-associated virus replication gene |
08/28/1996 | EP0728209A1 Endothelin-converting enzyme |
08/28/1996 | EP0728208A1 Tomato xyloglucan endo-transglycosylase |
08/28/1996 | EP0728204A1 Base-modified enzymatic nucleic acid |
08/28/1996 | EP0728203A1 Analogous peptides of the internal image of a viral protein |
08/28/1996 | EP0728202A1 Episomal expression vector for human gene therapy |
08/28/1996 | EP0728201A1 Brain-derived membrane-associated crf binding proteins |
08/28/1996 | EP0728200A1 Haemophilus transferrin receptor genes |
08/28/1996 | EP0728194A1 $i(IN SITU) MODIFICATION AND MANIPULATION OF STEM CELLS OF THE CENTRAL NERVOUS SYSTEM |
08/28/1996 | EP0728191A1 A secretion sequence for the production of a heterologous protein in yeast |
08/28/1996 | EP0728148A1 Improved immunogenic compositions against human gastrin 17 |
08/28/1996 | EP0728147A1 Receptor specific atrial natriuretic peptides |
08/28/1996 | EP0728146A1 Conotoxin peptides |
08/28/1996 | EP0728143A1 Oncoprotein protein kinase |
08/28/1996 | EP0728142A1 Novel antler-derived bone growth factors |
08/28/1996 | EP0728141A1 A method for identifying anti-parasitic compounds |
08/28/1996 | EP0728139A1 Amine-derivatized nucleosides and oligonucleosides |
08/28/1996 | EP0728023A1 Soluble factor stimulation of attachment and hemidesmosome assembly in epithelial cells |
08/28/1996 | EP0728015A1 Combinatorial polypeptide antigens |
08/28/1996 | EP0728014A1 Vaccines expressed in plants |
08/28/1996 | EP0728013A1 Compositions and method for stimulating antibody release by b lymphocytes |
08/28/1996 | EP0728012A1 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF |
08/28/1996 | EP0728011A1 Growth factor compositions, preparation and use |
08/28/1996 | EP0646182B1 Process for detection of neoplastic disease |
08/28/1996 | EP0571407B1 Cloning of a new member of the fibroblast growth factor (fgf) receptor family |
08/28/1996 | EP0406297B1 Medical use of neuropeptide Antagonist G |
08/28/1996 | EP0313578B1 Novel osteoinductive compositions |
08/28/1996 | EP0305387B2 Insulinotropic hormone |
08/28/1996 | CN1129984A Immunoassay for soluble fibrin polymers |
08/28/1996 | CN1129958A Method of identifying human and animal cells capable of unlimited proliferation or tumour formation |
08/28/1996 | CN1129955A A truncated keratinocyte growth factor (KGF) having increased biological activity |
08/28/1996 | CN1129954A Novel lipase, microorganism producing the lipase, process for producing the lipase and use of the lipase |
08/28/1996 | CN1129944A Novel protein and process for producing the same |
08/28/1996 | CN1129737A Modified protein for gene transfer and process for producing the same |
08/27/1996 | US5550318 Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
08/27/1996 | US5550316 Transgenic animal model system for human cutaneous melanoma |
08/27/1996 | US5550228 Vectors; transformed microorganisms and protoplasts; plant cells |
08/27/1996 | US5550223 Lipoprotein I (ompi) of pseudomonas aeruginosa |
08/27/1996 | US5550221 Genetic engineering |
08/27/1996 | US5550216 Gelatinase A inhibitor, and analytical reagent thereof for the determination of gelatinase A |
08/27/1996 | US5550214 Isolated antigenic oncogene peptide fragments and uses |
08/27/1996 | US5550213 Inhibitors of urokinase plasminogen activator |
08/27/1996 | US5550212 Analogues of hGH-RH(1-29)NH2 having antagonistic activity |
08/27/1996 | US5550188 Polymer conjugates ophthalmic devices comprising collagen-polymer conjugates |
08/27/1996 | US5550114 Infecting host kidney cells with fibroma virus, disrupting cells, filtering, adding methanol, centrifuging to remove precipitate, collecting epidermal growth factor inhibitor |
08/27/1996 | US5550110 Pentapeptide and hexapeptide analogs of endothelin-1 |
08/27/1996 | US5550109 Having antimicrobial, antifungal activity |
08/27/1996 | US5550108 Adding an 18 kda c5b-9 inhibitory protein to prevent platelet and endothelial cell activation |
08/27/1996 | US5550055 Recombinant DNA-produced T11 and fragments thereof |
08/27/1996 | US5550052 Useful for detection of lav antibodies in human sera |
08/27/1996 | US5550050 Exposing cells enclosed in biocompatible capsules to restrictive environmental conditions which match those which will be encountered after implantation until desired responses are established |
08/27/1996 | US5550049 Useful as insecticides and arachnicidic agents |
08/27/1996 | US5550045 Efficient production of enzyme useful for degrading pectin |
08/27/1996 | US5550043 Expression of heterologous proteins in Drosophila cells |
08/27/1996 | US5550042 Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors and genes encoding the same and serine protease inhibitor mutants and genes encoding the same |
08/27/1996 | US5550039 Oligonucleotide primers for HLA class I B locus DNA typing |
08/27/1996 | US5550038 Molecular farming |
08/27/1996 | US5550037 Dna clones |
08/27/1996 | US5550034 Apolipoprotein B mRNA editing protein compositions and methods |
08/27/1996 | US5550027 Screening blood donors for chagas disease |
08/27/1996 | US5550026 Antibodies to human gastrin-releasing peptide precursor and use thereof |
08/27/1996 | US5550023 Amplification of human MDM2 gene in human tumors |
08/27/1996 | US5550022 A nucleic acid molecule, atleast 27 nucleotides in length,specific for strains of listeria bacteria, hybridizes with specific nucleotide sequence or complementary sequence |
08/27/1996 | US5550019 Methods of identifying compounds which alter apoptosis |
08/27/1996 | US5550017 Anti-paramyxovirus screening method and vaccine |
08/27/1996 | US5549899 Culture product of strain of giardia lamblia and an adjuvant, used to treat intestinal protozoal infections in canine and feline species |
08/27/1996 | US5549898 Parasiticides |